The effect of tocilizumab on the uptake of 18FDG-PET imaging in patients with adult-onset Still's disease.
Cunha
Marcelo L
ML
Wagner
Jairo
J
Osawa
Akemi
A
Scheinberg
Morton
M
D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals / Q000378:metabolism*; D016706:Still's Disease, Adult-Onset / Q000175:diagnosis*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C502936:tocilizumab